SORA

Advancing, promoting and sharing knowledge of health through excellence in teaching, clinical practice and research into the prevention and treatment of illness

Genomic investigations of unexplained acute hepatitis in children.

Morfopoulou, S; Buddle, S; Torres Montaguth, OE; Atkinson, L; Guerra-Assunção, JA; Moradi Marjaneh, M; Zennezini Chiozzi, R; Storey, N; Campos, L; Hutchinson, JC; et al. Morfopoulou, S; Buddle, S; Torres Montaguth, OE; Atkinson, L; Guerra-Assunção, JA; Moradi Marjaneh, M; Zennezini Chiozzi, R; Storey, N; Campos, L; Hutchinson, JC; Counsell, JR; Pollara, G; Roy, S; Venturini, C; Antinao Diaz, JF; Siam, A; Tappouni, LJ; Asgarian, Z; Ng, J; Hanlon, KS; Lennon, A; McArdle, A; Czap, A; Rosenheim, J; Andrade, C; Anderson, G; Lee, JCD; Williams, R; Williams, CA; Tutill, H; Bayzid, N; Martin Bernal, LM; Macpherson, H; Montgomery, K-A; Moore, C; Templeton, K; Neill, C; Holden, M; Gunson, R; Shepherd, SJ; Shah, P; Cooray, S; Voice, M; Steele, M; Fink, C; Whittaker, TE; Santilli, G; Gissen, P; Kaufer, BB; Reich, J; Andreani, J; Simmonds, P; Alrabiah, DK; Castellano, S; Chikowore, P; Odam, M; Rampling, T; Houlihan, C; Hoschler, K; Talts, T; Celma, C; Gonzalez, S; Gallagher, E; Simmons, R; Watson, C; Mandal, S; Zambon, M; Chand, M; Hatcher, J; De, S; Baillie, K; Semple, MG; DIAMONDS Consortium; PERFORM Consortium; ISARIC 4C Investigators; Martin, J; Ushiro-Lumb, I; Noursadeghi, M; Deheragoda, M; Hadzic, N; Grammatikopoulos, T; Brown, R; Kelgeri, C; Thalassinos, K; Waddington, SN; Jacques, TS; Thomson, E; Levin, M; Brown, JR; Breuer, J (2023) Genomic investigations of unexplained acute hepatitis in children. Nature, 617 (7961). pp. 564-573. ISSN 1476-4687 https://doi.org/10.1038/s41586-023-06003-w
SGUL Authors: Drysdale, Simon Bruce

[img]
Preview
PDF Published Version
Available under License Creative Commons Attribution.

Download (10MB) | Preview
[img]
Preview
PDF (Reporting Summary) Supplemental Material
Download (5MB) | Preview
[img]
Preview
PDF (Peer Review File) Supplemental Material
Download (829kB) | Preview
[img] Microsoft Excel (Supplementary Table 1) Supplemental Material
Download (23kB)
[img] Microsoft Excel (Supplementary Table 2) Supplemental Material
Download (9kB)
[img] Microsoft Excel (Supplementary Table 3) Supplemental Material
Download (9kB)
[img] Microsoft Excel (Supplementary Table 4) Supplemental Material
Download (27kB)
[img] Microsoft Excel (Supplementary Table 5) Supplemental Material
Download (20kB)
[img] Microsoft Excel (Supplementary Table 6) Supplemental Material
Download (9kB)
[img] Microsoft Excel (Supplementary Table 7) Supplemental Material
Download (12kB)
[img] Microsoft Excel (Supplementary Table 8) Supplemental Material
Download (9kB)
[img] Microsoft Excel (Supplementary Table 9) Supplemental Material
Download (10kB)
[img] Microsoft Excel (Supplementary Table 10) Supplemental Material
Download (9kB)
[img] Microsoft Excel (Supplementary Table 11) Supplemental Material
Download (28kB)
[img] Microsoft Excel (Supplementary Table 12) Supplemental Material
Download (26kB)
[img] Microsoft Excel (Supplementary Table 13) Published Version
Download (250kB)
[img] Microsoft Excel (Supplementary Table 14) Published Version
Download (895kB)
[img] Microsoft Excel (Supplementary Table 15) Published Version
Download (9kB)

Abstract

Since its first identification in Scotland, over 1,000 cases of unexplained paediatric hepatitis in children have been reported worldwide, including 278 cases in the UK1. Here we report an investigation of 38 cases, 66 age-matched immunocompetent controls and 21 immunocompromised comparator participants, using a combination of genomic, transcriptomic, proteomic and immunohistochemical methods. We detected high levels of adeno-associated virus 2 (AAV2) DNA in the liver, blood, plasma or stool from 27 of 28 cases. We found low levels of adenovirus (HAdV) and human herpesvirus 6B (HHV-6B) in 23 of 31 and 16 of 23, respectively, of the cases tested. By contrast, AAV2 was infrequently detected and at low titre in the blood or the liver from control children with HAdV, even when profoundly immunosuppressed. AAV2, HAdV and HHV-6 phylogeny excluded the emergence of novel strains in cases. Histological analyses of explanted livers showed enrichment for T cells and B lineage cells. Proteomic comparison of liver tissue from cases and healthy controls identified increased expression of HLA class 2, immunoglobulin variable regions and complement proteins. HAdV and AAV2 proteins were not detected in the livers. Instead, we identified AAV2 DNA complexes reflecting both HAdV-mediated and HHV-6B-mediated replication. We hypothesize that high levels of abnormal AAV2 replication products aided by HAdV and, in severe cases, HHV-6B may have triggered immune-mediated hepatic disease in genetically and immunologically predisposed children.

Item Type: Article
Additional Information: Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. © The Author(s) 2023
Keywords: Child, Humans, Acute Disease, Adenovirus Infections, Human, B-Lymphocytes, Gene Expression Profiling, Genomics, Hepatitis, Immunohistochemistry, Liver, Proteomics, T-Lymphocytes, DIAMONDS Consortium, PERFORM Consortium, ISARIC 4C Investigators, Liver, B-Lymphocytes, T-Lymphocytes, Humans, Adenovirus Infections, Human, Hepatitis, Acute Disease, Immunohistochemistry, Gene Expression Profiling, Proteomics, Genomics, Child, General Science & Technology
SGUL Research Institute / Research Centre: Academic Structure > Infection and Immunity Research Institute (INII)
Journal or Publication Title: Nature
ISSN: 1476-4687
Language: eng
Dates:
DateEvent
May 2023Published
30 March 2023Published Online
23 March 2023Accepted
Publisher License: Creative Commons: Attribution 4.0
Projects:
Project IDFunderFunder ID
206478/Z/17/ZWellcome Trusthttp://dx.doi.org/10.13039/100004440
CO-CIN-01National Institute for Health and Care Researchhttp://dx.doi.org/10.13039/501100000272
CV220-169National Institute for Health Researchhttp://dx.doi.org/10.13039/501100000272
MC_PC_19059UK Research and Innovationhttp://dx.doi.org/10.13039/100014013
207511/Z/17/ZWellcome Trusthttp://dx.doi.org/10.13039/100004440
203268/Z/16/ZWellcome Trusthttp://dx.doi.org/10.13039/100004440
NIHR203338National Institute for Health Researchhttp://dx.doi.org/10.13039/501100000272
848196Horizon 2020http://dx.doi.org/10.13039/501100007601
668303Horizon 2020http://dx.doi.org/10.13039/501100007601
PubMed ID: 36996872
Web of Science ID: WOS:001022726200001
Go to PubMed abstract
URI: https://openaccess.sgul.ac.uk/id/eprint/116167
Publisher's version: https://doi.org/10.1038/s41586-023-06003-w

Actions (login required)

Edit Item Edit Item